Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
ApiJect Systems
AddedFeb 15, 2024
UpdatedJun 18, 2026
ApiJect Systems

ApiJect Systems

Private Equity

ApiJect Systems Corp., a CT-based medical firm, produces single-use prefilled injectors for pharmaceuticals and biotech.

HQ
Stamford, CT, US
Founded
2018
Overview
Compare
Fundraising
Employees
Website

ApiJect Systems Corporation, founded in 2018 by Marc Koska and based in Stamford, Connecticut, is a medical organization specializing in the production of pre-filled single-use plastic injectors. The company's core mission is to enhance the delivery of injectable medicines by providing scalable, cost-efficient drug delivery systems. ApiJect collaborates with pharmaceutical and biotech companies to fill their injectable drug products into single-dose prefilled injectors, leveraging Blow-Fill-Seal (BFS) aseptic drug packaging technology.

Notable figures associated with ApiJect include its founder Marc Koska, an innovator in medical device technology. The company has garnered attention for its capacity to manufacture pre-filled COVID-19 vaccine syringes by the end of 2020. ApiJect's key achievements include establishing a proof-of-concept at its Orlando Technology Development Center and advancing the integration of BFS technology in drug delivery. Overall, ApiJect has significantly impacted the pharmaceutical industry by improving the efficiency and safety of injectable drug administration.

ApiJect Systems - Similar Companies

Pharmajet logo

Pharmajet

pharmajet.com

American Injectables logo

American Injectables

americaninj.com

Enable Injections logo

Enable Injections

Portal Instruments logo

Portal Instruments

TheraJect logo

TheraJect

Diavibe logo

Diavibe

Genixus logo

Genixus

Aktivax logo

Aktivax

aktivax.com

Injectsense logo

Injectsense

injectsense.com

Qatch Technologies logo

Qatch Technologies

qatchtech.com

Pocket Clinic logo

Pocket Clinic

pocketclinic.life

SeeTrue Technology logo

SeeTrue Technology

West Pharmaceutical Services I logo

West Pharmaceutical Services I

westpharma.com

Bright Path Laboratories logo

Bright Path Laboratories

brightpathlabs.com

Vapocoolshot logo

Vapocoolshot

coolject.com

ApiJect Systems - Quick Facts

Who are ApiJect Systems' competitors?

Companies similar to ApiJect Systems include Pharmajet, American Injectables, Enable Injections and Portal Instruments.

When was ApiJect Systems founded?

ApiJect Systems was founded in 2018.

Where is ApiJect Systems' headquarters located?

ApiJect Systems' headquarters is located in Stamford, CT, US.

When was ApiJect Systems' last funding round?

ApiJect Systems' most recent funding round was for $111M (USD) in May 2022.

How much has ApiJect Systems raised to-date?

As of May 18, 2022, ApiJect Systems has raised a total of $111M (USD).

How many employees does ApiJect Systems have?

ApiJect Systems has 89 employees as of Feb 4, 2024.

ApiJect Systems - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • Manufacturing
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
  • Government
Main Product
  • Medical Devices
Tags
  • Biotech
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 21 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 330000Manufacturing
  • 325000Chemical Manufacturing
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 325410Pharmaceutical and Medicine Manufacturing
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 3900Miscellaneous Manufacturing Industries
  • 5000Wholesale Trade-durable Goods
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 2830Drugs
  • 5040Professional And Commercial Equipment And Supplies
  • 8730Research, Development, And Testing Services
  • 2834Pharmaceutical Preparations
  • 5047Medical, Dental, And Hospital Equipment And Supplies
  • 8731Commercial Physical and Biological Research